Alexandra Brandt

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 322 citations · Full text

Medicine, Oncology, Surgery +16

Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction

Femke J. Amelung, Wernard A. A. Borstlap, Esther C. J. Consten et al. · British journal of surgery · 2019 · 106 citations · Full text

Medicine, Oncology, Surgery +16

Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer

Guoying Zhou, Lisanne Noordam, Dave Sprengers et al. · OncoImmunology · 2018 · 77 citations · Full text

Life Sciences, Immunology, Oncology +17

Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study

Checca Bakkers, Felice N. van Erning, Koen P. Rovers et al. · European Journal of Surgical Oncology · 2020 · 37 citations · Full text

Medicine, Oncology, Surgery +17

Adjuvant HIPEC in patients with colon cancer at high risk of peritoneal metastases: Primary outcome of the COLOPEC multicenter randomized trial.

Charlotte Emma Louise Klaver, D D Wisselink, Cornelis J.A. Punt et al. · Journal of Clinical Oncology · 2019 · 28 citations

Medicine, Oncology, Chemotherapy +16